I wish I could tell you the "When". I wish it were tomorrow!! I've been learning about the timetables of biotech as IPIX experiences them, so I can only surmise based on what little I have learned of corporate things in general. When talking hundreds of millions (hopefully) it's always going to be a slow process. Honestly I am surprised with the 60-90 day timing Kelt and others posted from the articles about generic steps for term sheets and final DD. I would think it was longer. Then again there is a lot that should lead up to the spot where the 60-90 days kicks in, so maybe that is a good estimate. Of course all of that is just concerning the steps to sign a deal, get the boost in PPS, and get uplisted.

Getting a predicted valuation from a financial institution may happen soon after partnering and uplist, which will drive SP even more, but my educated guess is that the SP wont realize the high numbers until FDA approvals and maybe even revenue starting to be generated for one of the drugs. That has got to be a few years off still, even though I am prepared to wait out that end game value. That said; while it may take a few more years to get to the end game, once the first deal is inked, we uplist, and trials re-start again the SP will climb to a spot where it belongs and it will make it much easier for me to continue the waiting game with some healthy profits in my pockets.

I believe it is only blue sky ahead of us.